| Disease ID | Disease name | Reference |
|---|
| MESH:D000013 |
Congenital Abnormalities |
PMID:24830451 |
| MESH:D000067877 |
Autism Spectrum Disorder |
PMID:24284360; PMID:33765546 |
| MESH:D000072660 |
Teratozoospermia |
PMID:29549816 |
| MESH:D000077962 |
Body-Weight Trajectory |
PMID:30090589 |
| MESH:D000170 |
Acrodynia |
PMID:18485443 |
| MESH:D000419 |
Albuminuria |
PMID:18335109 |
| MESH:D000690 |
Amyotrophic Lateral Sclerosis |
PMID:27377857 |
| MESH:D000782 |
Aneuploidy |
PMID:30763314 |
| MESH:D001249 |
Asthma |
PMID:20562055 |
| MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
PMID:33765546 |
| MESH:D001321 |
Autistic Disorder |
PMID:17497416; PMID:24676906 |
| MESH:D001327 |
Autoimmune Diseases |
PMID:10820171; PMID:10857791; PMID:11007760; PMID:11171521; PMID:11490030; PMID:12743535; PMID:12825236; PMID:14599845; PMID:14616778; PMID:15522122; PMID:16634805; PMID:18641331; PMID:20176347; PMID:22136142; PMID:22578563; PMID:24818014; PMID:25237059; PMID:28453771; PMID:8513597; PMID:9931279 |
| MESH:D001724 |
Birth Weight |
PMID:20194072; PMID:32585550 |
| MESH:D001835 |
Body Weight |
PMID:23824410 |
| MESH:D002292 |
Carcinoma, Renal Cell |
PMID:39294077 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
PMID:10334427 |
| MESH:D002318 |
Cardiovascular Diseases |
PMID:18093879; PMID:20308036; PMID:20554312; PMID:22184584 |
| MESH:D002386 |
Cataract |
PMID:20716509 |
| MESH:D002493 |
Central Nervous System Diseases |
PMID:21998611 |
| MESH:D002869 |
Chromosome Aberrations |
PMID:17176674 |
| MESH:D003072 |
Cognition Disorders |
PMID:18226494 |
| MESH:D003324 |
Coronary Artery Disease |
PMID:28431391 |
| MESH:D003920 |
Diabetes Mellitus |
PMID:23423697 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
PMID:26497629 |
| MESH:D005076 |
Exanthema |
PMID:11390425 |
| MESH:D005128 |
Eye Diseases |
PMID:21473382 |
| MESH:D005234 |
Fatty Liver |
PMID:21126940 |
| MESH:D005262 |
Feminization |
PMID:22300406 |
| MESH:D006402 |
Hematologic Diseases |
PMID:30090589; PMID:38653421 |
| MESH:D006529 |
Hepatomegaly |
PMID:37676925 |
| MESH:D006942 |
Hypergammaglobulinemia |
PMID:11490030; PMID:18314309; PMID:25237059 |
| MESH:D006943 |
Hyperglycemia |
PMID:15531641 |
| MESH:D006967 |
Hypersensitivity |
PMID:10886235 |
| MESH:D006968 |
Hypersensitivity, Delayed |
PMID:11379047 |
| MESH:D006973 |
Hypertension |
PMID:23824410; PMID:26612503 |
| MESH:D007154 |
Immune System Diseases |
PMID:12849721; PMID:22080037 |
| MESH:D007160 |
Immunoproliferative Disorders |
PMID:12594276 |
| MESH:D007247 |
Infertility, Female |
PMID:12371497 |
| MESH:D007248 |
Infertility, Male |
PMID:16136024 |
| MESH:D007249 |
Inflammation |
PMID:16428073; PMID:25237059; PMID:28453771; PMID:8874531 |
| MESH:D007674 |
Kidney Diseases |
PMID:11090055; PMID:17068093; PMID:17934191; PMID:18540850; PMID:21206114; PMID:30090589; PMID:32909846 |
| MESH:D007859 |
Learning Disabilities |
PMID:23742082 |
| MESH:D007960 |
Leukocyte Disorders |
PMID:30090589 |
| MESH:D008232 |
Lymphoproliferative Disorders |
PMID:18314309 |
| MESH:D008569 |
Memory Disorders |
PMID:23742082 |
| MESH:D008607 |
Intellectual Disability |
PMID:22300406 |
| MESH:D008630 |
Mercury Poisoning |
PMID:16891999; PMID:18155151; PMID:18329067; PMID:18365070; PMID:18501191; PMID:18594997; PMID:19039081; PMID:19040355; PMID:21206114; PMID:21821123; PMID:22018916; PMID:22174729; PMID:23330093; PMID:24319713; PMID:24522097; PMID:26678598 |
| MESH:D009069 |
Movement Disorders |
PMID:19628251 |
| MESH:D009358 |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
PMID:18501191 |
| MESH:D009395 |
Nephritis, Interstitial |
PMID:10820171 |
| MESH:D009402 |
Nephrosis, Lipoid |
PMID:2947217 |
| MESH:D009404 |
Nephrotic Syndrome |
PMID:2947217 |
| MESH:D009410 |
Nerve Degeneration |
PMID:19288233 |
| MESH:D009422 |
Nervous System Diseases |
PMID:20929057 |
| MESH:D009461 |
Neurologic Manifestations |
PMID:22184584 |
| MESH:D009765 |
Obesity |
PMID:23824410; PMID:28029015 |
| MESH:D009845 |
Oligospermia |
PMID:29549816 |
| MESH:D010468 |
Perceptual Disorders |
PMID:26658153 |
| MESH:D010523 |
Peripheral Nervous System Diseases |
PMID:21998611 |
| MESH:D011236 |
Prediabetic State |
PMID:26497629 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
PMID:20194072; PMID:23603214; PMID:25748564; PMID:27262785; PMID:31421448; PMID:32176304 |
| MESH:D011507 |
Proteinuria |
PMID:10820171; PMID:2947217 |
| MESH:D012128 |
Respiratory Distress Syndrome |
PMID:26678598 |
| MESH:D012816 |
Signs and Symptoms |
PMID:25404430 |
| MESH:D013158 |
Splenic Diseases |
PMID:30090589 |
| MESH:D013163 |
Splenomegaly |
PMID:12928768; PMID:25237059 |
| MESH:D013959 |
Thyroid Diseases |
PMID:38797200 |
| MESH:D015228 |
Hypertriglyceridemia |
PMID:23824410 |
| MESH:D015352 |
Dry Eye Syndromes |
PMID:30746909 |
| MESH:D015431 |
Weight Loss |
PMID:12928768; PMID:30103553; PMID:37415728 |
| MESH:D015433 |
Glomerulonephritis, Membranous |
PMID:20089494 |
| MESH:D017449 |
Dermatitis, Allergic Contact |
PMID:16823706 |
| MESH:D017512 |
Lichenoid Eruptions |
PMID:18393961 |
| MESH:D019954 |
Neurobehavioral Manifestations |
PMID:21124968; PMID:23827881; PMID:25056781; PMID:25109824; PMID:25748564 |
| MESH:D020258 |
Neurotoxicity Syndromes |
PMID:20222982; PMID:20226812 |
| MESH:D020262 |
Mercury Poisoning, Nervous System |
PMID:18226494; PMID:18950830; PMID:21984480; PMID:30076900; PMID:7781173 |
| MESH:D024821 |
Metabolic Syndrome |
PMID:19221698; PMID:23824410; PMID:25053396; PMID:27420091; PMID:32176304 |
| MESH:D028361 |
Mitochondrial Diseases |
PMID:21146384 |
| MESH:D047928 |
Premature Birth |
PMID:32575788 |
| MESH:D048629 |
Micronuclei, Chromosome-Defective |
PMID:17456398 |
| MESH:D049188 |
Prenatal Injuries |
PMID:18501191 |
| MESH:D051346 |
Mobility Limitation |
PMID:25056781 |
| MESH:D056486 |
Chemical and Drug Induced Liver Injury |
PMID:22888199; PMID:37676925 |
| MESH:D058186 |
Acute Kidney Injury |
PMID:21073006; PMID:21821123 |
| MESH:D064806 |
Dysbiosis |
PMID:37137463 |
| MESH:D065886 |
Neurodevelopmental Disorders |
PMID:27262785 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.